MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
59.3 M |
Marktkapitalisierung |
$ 530 M |
EBITDA (LTM) |
$ -66.9 M |
P/E (LTM) |
-7.12 |
P/S (LTM) |
6.98 |
EPS (LTM) |
-1.29 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Castle Biosciences
CSTL
|
$ 38.85 | 2.32 % | $ 1.08 B | Nasdaq Global Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.36 | -4.05 % | $ 176 M | Nasdaq Global Market |  China |
 |
Brainsway Ltd.
BWAY
|
$ 17.05 | -2.15 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Danaher Corporation
DHR
|
$ 227.08 | -2.28 % | $ 166 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.58 | 0.21 % | $ 18.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 27.13 | 0.26 % | $ 820 M | Nasdaq Global Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.63 | -2.11 % | $ 2.07 M | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DexCom
DXCM
|
$ 66.91 | -2.94 % | $ 25.8 B | Nasdaq Global Select Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 11.92 | -6.58 % | $ 338 M | Nasdaq Capital Market | Israel |
 |
Illumina
ILMN
|
$ 134.29 | -1.58 % | $ 21.4 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 221.54 | -1.96 % | $ 40.2 B | NYSE,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 66.11 | 4.76 % | $ 4.57 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 102.09 | 0.7 % | $ 12.5 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 20.44 | 3.23 % | $ 1.1 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 105.26 | 4.46 % | $ 4.15 B | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.59 | -25.21 % | $ 115 K | Nasdaq Capital Market | USA |
 |
Co-Diagnostics
CODX
|
$ 0.34 | -2.96 % | $ 9.98 M | Nasdaq Capital Market | USA |
 |
Myriad Genetics
MYGN
|
$ 7.26 | -0.62 % | $ 658 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 6.86 | -2.63 % | $ 1.49 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.81 | 2.24 % | $ 437 M | Nasdaq Global Select Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 263.51 | -0.46 % | $ 22.1 B | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.13 | -1.61 % | $ 540 M | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.6 | -1.52 % | $ 20 B | NYSE |  Niderland |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 192.57 | -0.96 % | $ 9.89 B | NYSE,SPB | USA |
 |
Quidel Corporation
QDEL
|
$ 28.79 | -2.93 % | $ 1.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |  Schweiz |
 |
RadNet
RDNT
|
$ 75.0 | -4.65 % | $ 5.48 B | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 182.21 | 0.35 % | $ 20.2 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 7.94 | -1.0 % | $ 1.03 B | Nasdaq Global Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 186.28 | -1.92 % | $ 15.4 B | Nasdaq Global Select Market,SPB |  Irlanda |